5/21/17 HSCI Co-director David Scadden weighs in on for-profit stem cell clinics, calling stem cell tourism "a waste of money" in a Vogue article.
5/9/17 Undark Magazine features research from HSCI Co-director Doug Melton's lab in a photo story.
5/4/16 Leonard Zon explains how a small zebrafish can have a big impact on biomedical research in a STAT News video.
4/26/17 HSCI Nervous System Diseases Program co-lead Paola Arlotta develops a protocol that allows brain organoids to develop for more than nine months - longer than any other brain model to date. These organoids generate more diverse and mature cell types, including light-sensitive cells, than any other brain model. Featured: STAT News, Wired, University Herald, Harvard Gazette, Singularity Hub, BioNews
4/26/17 HSCI Principal Faculty Kevin Eggan finds that a percentage of stem cell lines acquire a cancer-causing mutation in vitro, including lines being prepared for clinical use. Featued: STAT News, Oncology Times, The Scientist, The San Diego Union-Tribune, GEN,
4/21//17 George Daley, HSCI Principal Faculty and Dean of the Harvard Medical School, talks to NPR about why the Medical School and area hospitals support the March for Science.
4/12/17 In an article for The Scientist, Amy Wagers comments on work that adds to the repertoire of tools and methods used to study Duchenne muscular dystrophy.
4/11/17 Nature highlights Magenta Therapeutics, a startup cofounded by HSCI co-director David Scadden and Derrick Rossi with the aim to revolutionize hematopoietic stem cell transplants, in their list of top academic spinouts from 2016.
3/30/17 Technology Networks highlights Yu-Hua Tseng's work on brown, energy-burning fat.
3/8/17 The ALS Forum covers Lee Rubin's most recent work towards finding therapies for neurodegenerative diseases targeting motor neurons.
3/1/17 Stuart Orkin comments on advances towards a therapy for sickle cell anemia in a New Scientist article.
10/20/2016 Non-profit organizations supporting research for Duchenne Muscular Dystrophy honor HSCI Principal Faculty Member Louis Kunkel at a charity event.
10/08/2016 Time covers HSCI Principal Faculty member Richard Lee's work understanding the relationship between fructose consumption/absorption and diabetes.
9/08/16 MIT News asked John Rinn, HSCI Principal Faculty member, for his expert opinion on the latest MIT research on lncRNA.
9/01/16 The Harvard Gazette highlights Paola Arlotta's work growing cerebral buds from iPS cells as one many exemplary innovative research projects on campus in an article about The Harvard Campaign.
8/17/2016 AllAfrica features HSCI Principal Faculty member Kornelia Polyak's work describing the mechanisms behind why women who give birth before 30 are less likely to develop breast cancer.
7/06/16 American Museum of Natural History profiles biotechnologist and entrepreneur Jeff Karp.
6/27/16 Bloomberg News examines the potential for growth of the regenerative medicine industry in the Japanese market, and HSCI Executive Director, Brock Reeve, provides insight to the state of the industry in the US.
6/24/16 HSCI Co-Founder David Scadden comments in a STAT article on FDA-approved (through the "compassionate use" exemption) stem cell procedure given to a lung cancer patient.
6/17/2016 HSCI Principal Faculty member George Murphy explains how cancer stem cells function within a tumor in a Science article.
6/8/16 NPR profiles Kit Parker, HSCI Principal Faculty member, focusing on how his friendship with Army buddy Chris Moroski influenced his decision to start studying traumatic brain injury.
5/27/16 Stuart Orkin writes about the economics of gene therapy development and the determination of cost and mark value in Science online.
5/11/16 A Tablet article about the science of aging highlights the work of HSCI Principal Faculty members Amy Wagers, Rich Lee and Lee Rubin, and HSCI Executive Director, Brock Reeve, provides context about the economic landscape of diseases of aging.
5/10/16 Chad Cowan, HSCI Principal Faculty member, speaks to Medscape about the history of stem cells and the future of medicine.
5/6 In a CBS Boston special report, HSCI Co-Director David Scadden comments on the exploitative nature of stem cell clinics offering untested therapies.
4/01/16 Healio covers Doug Melton, HSCI founding co-director, speech at the Endocrine Society's 98th annual meeting about his hope to one day replace insulin injections with cell therapy for diabetics.
3/25/16 Les Silberstein, an HSCI Principal Faculty member, explained to Medical Daily why A/B blood types are rare.
2/29/2016 George Q. Daley, HSCI Executive Committee member, questions the STAP process of making stem cells, effectively debunking the work. He describes that journey in a New Yorker article.
2/05/16 As a guest on the Science Friday podcast, HSCI Executive Committee member George Q. Daley details the scientific, ethical, and legal aspects of the U.K.'s Human Fertilization and Embryology Authority's decision to allow researchers to use CRISPR-Cas9 gene-editing in human embryos.
11/23/15 The Boston Globe photographs HSCI co-founder and co-director Doug Melton at the Joslin Diabetes Center's16th annual High Hopes Gala. Melton received a Global Achievement Award that night.
11/19/15 HSCI co-founder and co-director David Scadden speaks with CBS Chicago about the lack of scientific evidence and literature backing stem cell clinics and treatment centers.
11/19/15 Boston Business Journal publishes a Q&A with HSCI co-founder and co-director Doug Melton, who received a Global Achievement Award from Joslin Diabetes Center in recognition of his contributions to the field of diabetes research.
10/01/15 In The Scientist, an article exploring adult humans' ability to generate new neurons features the work of HSCI Principal Faculty Amar Sahay.
09/22/15 BBC News references HSCI Principal Faculty Member Harald Ott's work in an article about kidney regeneration.
09/18/15 An article in the Boston Globe pictures HSCI Executive Director Brock Reeve, who sat on a panel about gene and cell therapies at the BioPharma America conference.
09/02/15 An article published in the September issue of Discover Magazine features the work of HSCI Principal Faculty member Khalid Shah.
09/02/15 A Fox News article about stem cell tourism references a paper written and a panel organized by the Harvard Stem Cell Institute in 2013.
08/11/15 CNN features HSCI Principal Faculty member Harald Ott's limb regeneration work.
08/03/15 HSCI Principal Faculty member Olivier Pourquie's work generating muscle fibers to study muscular dystrophy is featured in Medical Daily.
08/01/15 In an article about nature-inspired bioengineering projects, The Scientist highlights the work of HSCI Principal Faculty member Jeff Karp.
03/24/15 The Boston Globe features Semma Therapeutics, a new biotech company commercializing research from HSCI Co-founder and Principal Faculty member Doug Melton's lab. The company has raised $44 million to begin developing insulin-secreting cell transplant therapies for patients with Type 1 diabetes.
03/19/2015 HSCI Principal Faculty member George Q. Daley comments on the emerging social and ethical implications of gene-editing technology in The New York Times.
03/13/15 A Science news feature about eye transplants mentions HSCI Principal Faculty member Zhigang He's work on optic nerve regeneration.
02/26/15 In The Scientist, the latest work in the lab of HSCI Principal Faculty Jeff Karp (Brigham and Women's Hospital/Harvard Medical School) has important implications for improving the efficacy of mesenchymal stem cells (MSCs) used in clinical trials.
01/21/15 A Nature news feature on efforts to apply the findings of parabiotic research on mice to humans features HSCI Principal Faculty member Amy Wagers.